CAR T-cell therapy for Australian patients with haematological malignancies will come without the international air miles as local manufacture ramps up. As of last week, Cell Therapies Pty Ltd is the first TGA-approved commercial manufacturer of tisagenlecleucel (Kymriah) at its facility at Melbourne’s Peter MacCallum Cancer Centre. Australia is one of seven manufacturing sites worldwide ...
Local CAR T-cell manufacture launched
By Mardi Chapman
16 Feb 2021